Literature DB >> 7611671

Diversity and patterns of regulation of nicotinic receptor subtypes.

R J Lukas1.   

Abstract

In our studies we explored the functional relevance of nAChR diversity, in part from the perspective of nAChR as ideal targets for regulatory influences, including those mediated via actions of ligands at other "interacting" receptors. We explored possible mechanisms for nAChR regulation and roles played by nAChR subtype and subunit diversity in those processes. We showed that regulatory factors can influence nAChR numbers at transcriptional and posttranscriptional levels and can affect nAChR function and subcellular distribution. We also demonstrated that nAChR expression can be influenced (1) by nicotinic ligands, (2) by second messengers, (3) by growth factors, (4) by agents targeting the nucleus, and (5) by agents targeting the cytoskeleton. We found common effects of some regulatory influences on more than one nAChR subtype, and we found instances where regulatory influences differ for different cell and nAChR types. Even from the very limited number of these initial studies, it is evident that nAChR subunit and subtype diversity, which alone can provide diversity in nAChR functions, localization, and ligand sensitivity, dovetails with diversity in cellular signaling mechanisms that can affect nAChR expression to amplify the potential functional plasticity of cholinoceptive cells. As examples, we discussed potential roles for nAChR diversity and regulatory plasticity in synapse remodeling and in changes in neuronal circuit conditions. These examples illustrate how nAChR diversity could play important roles in the regulation of nervous system function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611671     DOI: 10.1111/j.1749-6632.1995.tb17471.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  DNA methylation impacts on learning and memory in aging.

Authors:  Liang Liu; Thomas van Groen; Inga Kadish; Trygve O Tollefsbol
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

2.  Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.

Authors:  R J Lukas; C M Eisenhour
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

3.  Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Authors:  B Buisson; M Gopalakrishnan; S P Arneric; J P Sullivan; D Bertrand
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 4.  Naturally-expressed nicotinic acetylcholine receptor subtypes.

Authors:  Jie Wu; Ronald J Lukas
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

5.  Expression of nicotinic acetylcholine receptors and subunit messenger RNAs in the enteric nervous system of the neonatal rat.

Authors:  A Garza; L Z Huang; J-H Son; U H Winzer-Serhan
Journal:  Neuroscience       Date:  2008-11-21       Impact factor: 3.590

6.  Differential modulation of GABAA and NMDA receptors by α7-nicotinic receptor desensitization in cultured rat hippocampal neurons.

Authors:  Lei Shen; Wen-yu Cui; Ru-zhu Chen; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

7.  Suppression of complete Freund's adjuvant-induced adjuvant arthritis by cobratoxin.

Authors:  Yan-Li Liu; Hai-Ming Lin; Rong Zou; Jun-Chao Wu; Rong Han; Laurence N Raymond; Paul F Reid; Zheng-Hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-01-26       Impact factor: 6.150

8.  Cholinoreceptors of early (preneural) sea urchin embryos.

Authors:  G A Buznikov; L Rakich
Journal:  Neurosci Behav Physiol       Date:  2000 Jan-Feb

9.  Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.

Authors:  Qiang Liu; Paul Whiteaker; Barbara J Morley; Fu-Dong Shi; Ronald J Lukas
Journal:  Front Cell Neurosci       Date:  2017-09-22       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.